Browse Arkansas Code titles and sections
21 U.S.C. § 360d — Performance standards
Federal law — U.S. Code and appendices · legal_authorities
Page 344
TITLE 21—FOOD AND DRUGS
§ 360d
Editorial Notes
CODIFICATION
Section was enacted as part of the Food and Drug Ad-
ministration Safety and Innovation Act, and not as
part of the Federal Food, Drug, and Cosmetic Act
which comprises this chapter.
§ 360d. Performance standards
(a) Reasonable assurance of safe and effective
performance; periodic evaluation
(1) The special controls required by section
360c(a)(1)(B) of this title shall include perform-
ance standards for a class II device if the Sec-
retary determines that a performance standard
is necessary to provide reasonable assurance of
the safety and effectiveness of the device. A
class III device may also be considered a class II
device for purposes of establishing a standard
for the device under subsection (b) if the device
has been reclassified as a class II device under
an administrative order under section 360c(e) of
this title (or a regulation promulgated under
such section prior to July 9, 2012) but such order
(or regulation) provides that the reclassification
is not to take effect until the effective date of
such a standard for the device.
(2) A performance standard established under
subsection (b) for a device—
(A) shall include provisions to provide rea-
sonable assurance of its safe and effective per-
formance;
(B) shall, where necessary to provide reason-
able assurance of its safe and effective per-
formance, include—
(i) provisions respecting the construction,
components, ingredients, and properties of
the device and its compatibility with power
systems and connections to such systems,
(ii) provisions for the testing (on a sample
basis or, if necessary, on an individual basis)
of the device or, if it is determined that no
other more practicable means are available
t
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 360d
Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.
Original supplied file — preserved unchanged
Download original Markdown file
File SHA-256: 4103f6c4ca8361fd0102912572b21c2d16ae4d5b77c581cd9ab38d145c047f94. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.
Authority boundary: historical or unconfirmed source not current law verified.
Open the recorded source website ↗
Record provenance
Stable record: federal_law:legal_authorities:usc2024-dca0546c88522bd8f8cc5cb7
Source file: Laws/federal/codes/united-states-code-2024/title-21/section-360d-performance-standards--ac003d96a7.md
Pages: Not recorded – Not recorded
Passage SHA-256: 491d5772e1372e21b278e7f9751fc3ac9444603018a9e8804254f830535b2d83
Source location: USCODE-2024-title21-chap9-subchapV-partA-sec360d.pdf
Stored source content
Page 344
TITLE 21—FOOD AND DRUGS
§ 360d
Editorial Notes
CODIFICATION
Section was enacted as part of the Food and Drug Ad-
ministration Safety and Innovation Act, and not as
part of the Federal Food, Drug, and Cosmetic Act
which comprises this chapter.
§ 360d. Performance standards
(a) Reasonable assurance of safe and effective
performance; periodic evaluation
(1) The special controls required by section
360c(a)(1)(B) of this title shall include perform-
ance standards for a class II device if the Sec-
retary determines that a performance standard
is necessary to provide reasonable assurance of
the safety and effectiveness of the device. A
class III device may also be considered a class II
device for purposes of establishing a standard
for the device under subsection (b) if the device
has been reclassified as a class II device under
an administrative order under section 360c(e) of
this title (or a regulation promulgated under
such section prior to July 9, 2012) but such order
(or regulation) provides that the reclassification
is not to take effect until the effective date of
such a standard for the device.
(2) A performance standard established under
subsection (b) for a device—
(A) shall include provisions to provide rea-
sonable assurance of its safe and effective per-
formance;
(B) shall, where necessary to provide reason-
able assurance of its safe and effective per-
formance, include—
(i) provisions respecting the construction,
components, ingredients, and properties of
the device and its compatibility with power
systems and connections to such systems,
(ii) provisions for the testing (on a sample
basis or, if necessary, on an individual basis)
of the device or, if it is determined that no
other more practicable means are available
to the Secretary to assure the conformity of
the device to the standard, provisions for the
testing (on a sample basis or, if necessary,
on an individual basis) by the Secretary or
by another person at the direction of the
Secretary,
(iii) provisions for the measurement of the
performance characteristics of the device,
(iv) provisions requiring that the results of
each or of certain of the tests of the device
required to be made under clause (ii) show
that the device is in conformity with the
portions of the standard for which the test
or tests were required, and
(v) a provision requiring that the sale and
distribution of the device be restricted but
only to the extent that the sale and distribu-
tion of a device may be restricted under a
regulation under section 360j(e) of this title;
and
(C) shall, where appropriate, require the use
and prescribe the form and content of labeling
for the proper installation, maintenance, oper-
ation, and use of the device.
(3) The Secretary shall provide for periodic
evaluation of performance standards established
under subsection (b) to determine if such stand-
ards should be changed to reflect new medical,
scientific, or other technological data.
(4) In carrying out his duties under this sub-
section and subsection (b), the Secretary shall,
to the maximum extent practicable—
(A) use personnel, facilities, and other tech-
nical support available in other Federal agen-
cies,
(B) consult with other Federal agencies con-
cerned with standard-setting and other nation-
ally or internationally recognized standard-
setting entities, and
(C) invite appropriate participation, through
joint or other conferences, workshops, or other
means, by informed persons representative of
scientific, professional, industry, or consumer
organizations who in his judgment can make a
significant contribution.
(b) Establishment of a standard
(1)(A) The Secretary shall publish in the Fed-
eral Register a notice of proposed rulemaking
for the establishment, amendment, or revoca-
tion of any performance standard for a device.
(B) A notice of proposed rulemaking for the es-
tablishment or amendment of a performance
standard for a device shall—
(i) set forth a finding with supporting jus-
tification that the performance standard is ap-
propriate and necessary to provide reasonable
assurance of the safety and effectiveness of
the device,
(ii) set forth proposed findings with respect
to the risk of illness or injury that the per-
formance standard is intended to reduce or
eliminate,
(iii) invite interested persons to submit to
the Secretary, within 30 days of the publica-
tion of the notice, requests for changes in the
classification of the device pursuant to section
360c(e) of this title based on new information
relevant to the classification, and
(iv) invite interested persons to submit an
existing performance standard for the device,
including a draft or proposed performance
standard, for consideration by the Secretary.
(C) A notice of proposed rulemaking for the
revocation of a performance standard shall set
forth a finding with supporting justification
that the performance standard is no longer nec-
essary to provide reasonable assurance of the
safety and effectiveness of a device.
(D) The Secretary shall provide for a comment
period of not less than 60 days.
(2) If, after publication of a notice in accord-
ance with paragraph (1), the Secretary receives
a request for a change in the classification of
the device, the Secretary shall, within 60 days of
the publication of the notice, after consultation
with the appropriate panel under section 360c of
this title, either deny the request or give notice
of an intent to initiate such change under sec-
tion 360c(e) of this title.
(3)(A) After the expiration of the period for
comment on a notice of proposed rulemaking
published under paragraph (1) respecting a per-
formance standard and after consideration of
such comments and any report from an advisory
committee under paragraph (5), the Secretary
shall (i) promulgate a regulation establishing a
performance standard and publish in the Federal
Page 345
TITLE 21—FOOD AND DRUGS
§ 360d
Register findings on the matters referred to in
paragraph (1), or (ii) publish a notice termi-
nating the proceeding for the development of
the standard together with the reasons for such
termination. If a notice of termination is pub-
lished, the Secretary shall (unless such notice is
issued because the device is a banned device
under section 360f of this title) initiate a pro-
ceeding under section 360c(e) of this title to re-
classify the device subject to the proceeding ter-
minated by such notice.
(B) A regulation establishing a performance
standard shall set forth the date or dates upon
which the standard shall take effect, but no such
regulation may take effect before one year after
the date of its publication unless (i) the Sec-
retary determines that an earlier effective date
is necessary for the protection of the public
health and safety, or (ii) such standard has been
established for a device which, effective upon
the effective date of the standard, has been re-
classified from class III to class II. Such date or
dates shall be established so as to minimize,
consistent with the public health and safety,
economic loss to, and disruption or dislocation
of, domestic and international trade.
(4)(A) The Secretary, upon his own initiative
or upon petition of an interested person may by
regulation, promulgated in accordance with the
requirements of paragraphs (1), (2), and (3)(B) of
this subsection, amend or revoke a performance
standard.
(B) The Secretary may declare a proposed
amendment of a performance standard to be ef-
fective on and after its publication in the Fed-
eral Register and until the effective date of any
final action taken on such amendment if he de-
termines that making it so effective is in the
public interest. A proposed amendment of a per-
formance standard made so effective under the
preceding sentence may not prohibit, during the
period in which it is so effective, the introduc-
tion or delivery for introduction into interstate
commerce of a device which conforms to such
standard without the change or changes pro-
vided by such proposed amendment.
(5)(A) The Secretary—
(i) may on his own initiative refer a pro-
posed
regulation
for
the
establishment,
amendment, or revocation of a performance
standard, or
(ii) shall, upon the request of an interested
person which demonstrates good cause for re-
ferral and which is made before the expiration
of the period for submission of comments on
such proposed regulation refer such proposed
regulation,
to an advisory committee of experts, established
pursuant to subparagraph (B), for a report and
recommendation with respect to any matter in-
volved in the proposed regulation which requires
the exercise of scientific judgment. If a proposed
regulation is referred under this subparagraph
to an advisory committee, the Secretary shall
provide the advisory committee with the data
and information on which such proposed regula-
tion is based. The advisory committee shall,
within sixty days of the referral of a proposed
regulation and after independent study of the
data and information furnished to it by the Sec-
retary and other data and information before it,
submit to the Secretary a report and rec-
ommendation respecting such regulation, to-
gether with all underlying data and information
and a statement of the reason or basis for the
recommendation. A copy of such report and rec-
ommendation shall be made public by the Sec-
retary.
(B) The Secretary shall establish advisory
committees (which may not be panels under sec-
tion 360c of this title) to receive referrals under
subparagraph (A). The Secretary shall appoint
as members of any such advisory committee per-
sons qualified in the subject matter to be re-
ferred to the committee and of appropriately di-
versified professional background, except that
the Secretary may not appoint to such a com-
mittee any individual who is in the regular full-
time employ of the United States and engaged
in the administration of this chapter. Each such
committee shall include as nonvoting members
a representative of consumer interests and a
representative of interests of the device manu-
facturing industry. Members of an advisory
committee who are not officers or employees of
the United States, while attending conferences
or meetings of their committee or otherwise
serving at the request of the Secretary, shall be
entitled to receive compensation at rates to be
fixed by the Secretary, which rates may not ex-
ceed the daily equivalent of the rate in effect for
grade GS–18 of the General Schedule, for each
day (including traveltime) they are so engaged;
and while so serving away from their homes or
regular places of business each member may be
allowed travel expenses, including per diem in
lieu of subsistence, as authorized by section 5703
of title 5 for persons in the Government service
employed intermittently. The Secretary shall
designate one of the members of each advisory
committee to serve as chairman thereof. The
Secretary shall furnish each advisory committee
with clerical and other assistance, and shall by
regulation prescribe the procedures to be fol-
lowed by each such committee in acting on re-
ferrals made under subparagraph (A).
(c) Recognition of standard
(1)(A) In addition to establishing a perform-
ance standard under this section, the Secretary
shall, by publication in the Federal Register (or,
with respect to a susceptibility test interpretive
criteria standard under section 360a–2 of this
title, by posting on the Interpretive Criteria
Website in accordance with such section), recog-
nize all or part of an appropriate standard estab-
lished by a nationally or internationally recog-
nized standard development organization for
which a person may submit a declaration of con-
formity in order to meet a premarket submis-
sion requirement or other requirement under
this chapter to which such standard is applica-
ble.
(B) If a person elects to use a standard recog-
nized by the Secretary under subparagraph (A)
to meet the requirements described in such sub-
paragraph, the person shall provide a declara-
tion of conformity to the Secretary that cer-
tifies that the device is in conformity with such
standard. A person may elect to use data, or in-
formation, other than data required by a stand-
ard recognized under subparagraph (A) to meet
Page 346
TITLE 21—FOOD AND DRUGS
§ 360d
1 So in original. Probably should be ‘‘standard development or-
ganization.’’
any requirement regarding devices under this
chapter.
(C)(i) Any person may submit a request for
recognition under subparagraph (A) of all or
part of an appropriate standard established by a
nationally or internationally recognized stand-
ard organization.1
(ii) Not later than 60 calendar days after the
Secretary receives such a request, the Secretary
shall—
(I) make a determination to recognize all,
part, or none of the standard that is the sub-
ject of the request; and
(II) issue to the person who submitted such
request a response in writing that states the
Secretary’s rationale for that determination,
including the scientific, technical, regulatory,
or other basis for such determination.
(iii) The Secretary shall make a response
issued under clause (ii)(II) publicly available, in
such a manner as the Secretary determines ap-
propriate.
(iv) The Secretary shall take such actions as
may be necessary to implement all or part of a
standard recognized under clause (ii)(I), in ac-
cordance with subparagraph (A).
(D) The Secretary shall make publicly avail-
able, in such manner as the Secretary deter-
mines appropriate, the rationale for recognition
under subparagraph (A) of all, part, or none of a
standard, including the scientific, technical,
regulatory, or other basis for the decision re-
garding such recognition.
(2) The Secretary may withdraw such recogni-
tion of a standard through publication of a no-
tice in the Federal Register if the Secretary de-
termines that the standard is no longer appro-
priate for meeting a requirement regarding de-
vices under this chapter.
(3)(A) Subject to subparagraph (B), the Sec-
retary shall accept a declaration of conformity
that a device is in conformity with a standard
recognized under paragraph (1) unless the Sec-
retary finds—
(i) that the data or information submitted to
support such declaration does not demonstrate
that the device is in conformity with the
standard identified in the declaration of con-
formity; or
(ii) that the standard identified in the dec-
laration of conformity is not applicable to the
particular device under review.
(B) The Secretary may request, at any time,
the data or information relied on by the person
to make a declaration of conformity with re-
spect to a standard recognized under paragraph
(1).
(C) A person making a declaration of con-
formity with respect to a standard recognized
under paragraph (1) shall maintain the data and
information demonstrating conformity of the
device to the standard for a period of two years
after the date of the classification or approval of
the device by the Secretary or a period equal to
the expected design life of the device, whichever
is longer.
(4) The Secretary shall provide to all employ-
ees of the Food and Drug Administration who
review premarket submissions for devices peri-
odic training on the concept and use of recog-
nized standards for purposes of meeting a pre-
market submission requirement or other appli-
cable requirement under this chapter, including
standards relevant to an employee’s area of de-
vice review.
(d) Accreditation scheme for conformity assess-
ment
(1) In general
The Secretary shall establish a program
under which—
(A) testing laboratories meeting criteria
specified in guidance by the Secretary may
be accredited, by accreditation bodies meet-
ing criteria specified in guidance by the Sec-
retary, to conduct testing to support the as-
sessment of the conformity of a device to
certain standards recognized under this sec-
tion; and
(B) subject to paragraph (2), results from
tests conducted to support the assessment of
conformity of devices as described in sub-
paragraph (A) conducted by testing labora-
tories accredited pursuant to this subsection
shall be accepted by the Secretary for pur-
poses of demonstrating such conformity un-
less the Secretary finds that certain results
of such tests should not be so accepted.
(2) Secretarial review of accredited laboratory
results
The Secretary may—
(A) review the results of tests conducted
by testing laboratories accredited pursuant
to this subsection, including by conducting
periodic audits of such results or of the proc-
esses of accredited bodies or testing labora-
tories;
(B) following such review, take additional
measures under this chapter, as the Sec-
retary determines appropriate, such as—
(i) suspension or withdrawal of accredi-
tation of a testing laboratory or recogni-
tion of an accreditation body under para-
graph (1)(A); or
(ii) requesting additional information
with respect to a device; and
(C) if the Secretary becomes aware of in-
formation materially bearing on the safety
or effectiveness of a device for which an as-
sessment of conformity was supported by
testing conducted by a testing laboratory
accredited under this subsection, take such
additional measures under this chapter, as
the Secretary determines appropriate, such
as—
(i) suspension or withdrawal of accredi-
tation of a testing laboratory or recogni-
tion of an accreditation body under para-
graph (1)(A); or
(ii) requesting additional information
with regard to such device.
(3) Report
The Secretary shall make available on the
internet website of the Food and Drug Admin-
istration an annual report on the progress of
the program under this subsection.
(June 25, 1938, ch. 675, § 514, as added Pub. L.
94–295, § 2, May 28, 1976, 90 Stat. 546; amended
Page 347
TITLE 21—FOOD AND DRUGS
§ 360d
Pub. L. 94–460, title III, § 304, Oct. 8, 1976, 90 Stat.
1960; Pub. L. 101–629, §§ 6(a), (b)(1), 18(b), Nov. 28,
1990, 104 Stat. 4519, 4528; Pub. L. 102–300, § 6(g),
June 16, 1992, 106 Stat. 241; Pub. L. 103–80,
§ 4(a)(1), Aug. 13, 1993, 107 Stat. 779; Pub. L.
105–115, title II, § 204(a), (d), Nov. 21, 1997, 111
Stat. 2335, 2336; Pub. L. 112–144, title VI,
§ 608(a)(2)(B), July 9, 2012, 126 Stat. 1056; Pub. L.
114–255, div. A, title III, §§ 3044(b)(3), 3053(a), Dec.
13, 2016, 130 Stat. 1121, 1125; Pub. L. 115–52, title
II, § 205(a), Aug. 18, 2017, 131 Stat. 1016; Pub. L.
117–180, div. F, title II, § 2005, Sept. 30, 2022, 136
Stat. 2153.)
Editorial Notes
AMENDMENTS
2022—Subsec. (d). Pub. L. 117–180 amended subsec. (d)
generally. Prior to amendment, subsec. (d) related to a
pilot program for accrediting laboratories to assess de-
vice conformance.
2017—Subsec. (d). Pub. L. 115–52 added subsec. (d).
2016—Subsec. (c)(1)(A). Pub. L. 114–255, § 3044(b)(3), in-
serted ‘‘(or, with respect to a susceptibility test inter-
pretive criteria standard under section 360a–2 of this
title, by posting on the Interpretive Criteria Website in
accordance with such section)’’ after ‘‘the Secretary
shall, by publication in the Federal Register’’.
Subsec. (c)(1)(C), (D). Pub. L. 114–255, § 3053(a)(1),
added subpars. (C) and (D).
Subsec. (c)(4). Pub. L. 114–255, § 3053(a)(2), added par.
(4).
2012—Subsec. (a)(1). Pub. L. 112–144 substituted
‘‘under an administrative order under section 360c(e) of
this title (or a regulation promulgated under such sec-
tion prior to July 9, 2012) but such order (or regula-
tion)’’ for ‘‘under a regulation under section 360c(e) of
this title but such regulation’’.
1997—Subsec. (a)(1). Pub. L. 105–115, § 204(d)(1), sub-
stituted ‘‘under subsection (b)’’ for ‘‘under this sec-
tion’’.
Subsec. (a)(2). Pub. L. 105–115, § 204(d)(2), substituted
‘‘under subsection (b)’’ for ‘‘under this section’’ in in-
troductory provisions.
Subsec. (a)(3). Pub. L. 105–115, § 204(d)(3), substituted
‘‘under subsection (b)’’ for ‘‘under this section’’.
Subsec. (a)(4). Pub. L. 105–115, § 204(d)(4), substituted
‘‘this subsection and subsection (b)’’ for ‘‘this section’’
in introductory provisions.
Subsec. (c). Pub. L. 105–115, § 204(a), added subsec. (c).
1993—Subsec.
(b)(4)(B),
(5)(A)(ii). Pub. L.
103–80
amended directory language of Pub. L. 101–619, § 18(b),
identical to amendment by Pub. L. 102–300, § 6(g)(1). See
1992 and 1990 Amendment notes below.
1992—Subsec. (b)(4)(B), (5)(A)(ii). Pub. L. 102–300 made
technical corrections to directory language of Pub. L.
101–629, § 18(b)(1), (2). See 1990 Amendment note below.
1990—Subsec. (a)(1). Pub. L. 101–629, § 6(a)(1), sub-
stituted ‘‘The special controls required by section
360c(a)(1)(B) of this title shall include performance
standards for a class II device if the Secretary deter-
mines that a performance standard is necessary to pro-
vide reasonable assurance of the safety and effective-
ness of the device.’’ for ‘‘The Secretary may by regula-
tion, promulgated in accordance with this section, es-
tablish a performance standard for a class II device.’’
Subsec. (b). Pub. L. 101–629, § 6(a)(2), (3), redesignated
subsec. (g) as (b) and struck out former subsec. (b)
which read as follows:
‘‘(1) A proceeding for the development of a perform-
ance standard for a device shall be initiated by the Sec-
retary by the publication in the Federal Register of no-
tice of the opportunity to submit to the Secretary a re-
quest (within fifteen days of the date of the publication
of the notice) for a change in the classification of the
device based on new information relevant to its classi-
fication.
‘‘(2) If, after publication of a notice pursuant to para-
graph (1) the Secretary receives a request for a change
in the device’s classification, he shall, within sixty
days of the publication of such notice and after con-
sultation with the appropriate panel under section 360c
of this title, by order published in the Federal Register,
either deny the request for change in classification or
give notice of his intent to initiate such a change under
section 360c(e) of this title.’’
Subsec. (b)(1), (2). Pub. L. 101–629, § 6(a)(4), amended
pars. (1) and (2) generally. Prior to amendment, pars.
(1) and (2) read as follows:
‘‘(1)(A) After publication pursuant to subsection (c) of
this section of a notice respecting a performance stand-
ard for a device, the Secretary shall either—
‘‘(i) publish, in the Federal Register in a notice of
proposed rulemaking, a proposed performance stand-
ard for the device (I) developed by an offeror under
such notice and accepted by the Secretary, (II) devel-
oped under subsection (c)(4) of this section, (III) ac-
cepted by the Secretary under subsection (d) of this
section, or (IV) developed by him under subsection (f)
of this section, or
‘‘(ii) issue a notice in the Federal Register that the
proceeding is terminated together with the reasons
for such termination.
‘‘(B) If the Secretary issues under subparagraph
(A)(ii) a notice of termination of a proceeding to estab-
lish a performance standard for a device, he shall (un-
less such notice is issued because the device is a banned
device under section 360f of this title) initiate a pro-
ceeding under section 360c(e) of this title to reclassify
the device subject to the proceeding terminated by
such notice.
‘‘(2) A notice of proposed rulemaking for the estab-
lishment of a performance standard for a device pub-
lished under paragraph (1)(A)(i) shall set forth proposed
findings with respect to the degree of the risk of illness
or injury designed to be eliminated or reduced by the
proposed standard and the benefit to the public from
the device.’’
Subsec. (b)(3)(A)(i). Pub. L. 101–629, § 6(b)(1)(A), sub-
stituted ‘‘paragraph (1)’’ for ‘‘paragraph (2)’’.
Subsec. (b)(4)(A). Pub. L. 101–629, § 6(b)(1)(B), sub-
stituted ‘‘paragraphs (1), (2), and (3)(B)’’ for ‘‘para-
graphs (2) and (3)(B)’’.
Subsec. (b)(4)(B). Pub. L. 101–629, § 18(b)(1), as amend-
ed by Pub. L. 102–300, § 6(g)(1), (2), and Pub. L. 103–80,
§ 4(a)(1), struck out ‘‘, after affording all interested per-
sons an opportunity for an informal hearing,’’ after ‘‘if
he determines’’.
Subsec. (b)(5)(A)(ii). Pub. L. 101–629, § 18(b)(2), as
amended by Pub. L. 102–300, § 6(g)(1), (3), and Pub. L.
103–80, § 4(a)(1), substituted ‘‘which demonstrates good
cause for referral and which is made before the expira-
tion of the period for submission of comments on such
proposed regulation refer such proposed regulation,’’
for ‘‘unless the Secretary finds the request to be with-
out good cause or the request is made after the expira-
tion of the period for submission of comments on such
proposed regulation refer such proposed regulation,’’.
Subsecs. (c) to (f). Pub. L. 101–629, § 6(a)(2), struck out
subsec. (c) relating to invitations for standards, subsec.
(d) relating to acceptance of certain existing standards,
subsec. (e) relating to acceptance of offers to develop
standards, and subsec. (f) relating to development of
standards by the Secretary after publication of notice
inviting submissions or offers of standards.
Subsec. (g). Pub. L. 101–629, § 6(a)(3), redesignated sub-
sec. (g) as (b).
1976—Subsec. (a). Pub. L. 94–460 redesignated pars. (4)
and (5) as (3) and (4), respectively. Section as originally
enacted contained no par. (3).
Statutory Notes and Related Subsidiaries
EFFECTIVE DATE OF 2022 AMENDMENT
Pub. L. 117–180, div. F, title II, § 2008, Sept. 30, 2022, 136
Stat. 2154, provided that: ‘‘The amendments made by
this title [amending this section and sections 360m and
379i to 379j–1 of this title and repealing provisions set
Page 348
TITLE 21—FOOD AND DRUGS
§ 360e
out as notes under sections 379i and 379j–1 of this title]
shall take effect on October 1, 2022, or the date of the
enactment of this Act [Sept. 30, 2022], whichever is
later, except that fees under part 3 of subchapter C of
chapter VII of the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 379i et seq.) shall be assessed for all sub-
missions listed in section 738(a)(2)(A) of such Act [21
U.S.C. 379j(a)(2)(A)] received on or after October 1, 2022,
regardless of the date of the enactment of this Act.’’
EFFECTIVE DATE OF 2017 AMENDMENT
Amendment by Pub. L. 115–52 effective Oct. 1, 2017,
with fees under subpart 3 of part C of subchapter VII of
this chapter to be assessed for all submissions listed in
section 379j(a)(2)(A) of this title received on or after
Oct. 1, 2017, see section 209 of Pub. L. 115–52, set out as
a note under section 379i of this title.
EFFECTIVE DATE OF 1997 AMENDMENT
Amendment by Pub. L. 105–115 effective 90 days after
Nov. 21, 1997, except as otherwise provided, see section
501 of Pub. L. 105–115, set out as a note under section 321
of this title.
CONSTRUCTION OF 2016 AMENDMENT
Nothing in amendment by section 3044(b)(3) of Pub. L.
114–255 to be construed to restrict the prescribing of
antimicrobial drugs or other products, including drugs
approved under section 356(h) of this title, by health
care professionals, or to limit the practice of health
care, see section 3043 of Pub. L. 114–255, set out as a
note under section 356 of this title.
TERMINATION OF ADVISORY COMMITTEES
Advisory committees in existence on Jan. 5, 1973, to
terminate not later than the expiration of the 2-year
period following Jan. 5, 1973, and advisory committees
established after Jan. 5, 1973, to terminate not later
than the expiration of the 2-year period beginning on
the date of their establishment, unless in the case of a
committee established by the President or an officer of
the Federal Government, such committee is renewed by
appropriate action prior to the expiration of such 2-
year period, or in the case of a committee established
by Congress, its duration is otherwise provided by law.
See section 1013 of Title 5, Government Organization
and Employees.
GUIDANCE
Pub. L. 114–255, div. A, title III, § 3053(b), Dec. 13, 2016,
130 Stat. 1125, provided that: ‘‘The Secretary of Health
and Human Services, acting through the Commissioner
of Food and Drugs, shall review and update, if nec-
essary, previously published guidance and standard op-
erating procedures identifying the principles for recog-
nizing standards, and for withdrawing the recognition
of standards, under section 514(c) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 360d(c)), taking into
account the experience with and reliance on a standard
by foreign regulatory authorities and the device indus-
try, and whether recognition of a standard will pro-
mote harmonization among regulatory authorities in
the regulation of devices.’’
REFERENCES IN OTHER LAWS TO GS–16, 17, OR 18 PAY
RATES
References in laws to the rates of pay for GS–16, 17,
or 18, or to maximum rates of pay under the General
Schedule, to be considered references to rates payable
under specified sections of Title 5, Government Organi-
zation and Employees, see section 529 [title I, § 101(c)(1)]
of Pub. L. 101–509, set out in a note under section 5376
of Title 5.
§ 360e. Premarket approval
(a) General requirement
A class III device—
(1) which is subject to an order issued under
subsection (b) (or a regulation promulgated
under such subsection prior to July 9, 2012); or
(2) which is a class III device because of sec-
tion 360c(f) of this title,
is required to have, unless exempt under section
360j(g) of this title, an approval under this sec-
tion of an application for premarket approval
or, as applicable, an approval under subsection
(c)(2) of a report seeking premarket approval.
(b) Order to require premarket approval
(1) In the case of a class III device which—
(A) was introduced or delivered for introduc-
tion into interstate commerce for commercial
distribution before May 28, 1976; or
(B) is (i) of a type so introduced or delivered,
and (ii) is substantially equivalent to another
device within that type,
the Secretary shall by administrative order fol-
lowing publication of a proposed order in the
Federal Register, a meeting of a device classi-
fication panel described in section 360c(b) of this
title, and consideration of comments from all af-
fected stakeholders, including patients, payors,
and providers, notwithstanding subchapter II of
chapter 5 of title 5, require that such device
have an approval under this section of an appli-
cation for premarket approval. Authority to
issue such administrative order shall not be del-
egated below the Director of the Center for De-
vices and Radiological Health, acting in con-
sultation with the Commissioner.
(2) A proposed order required under paragraph
(1) shall contain—
(A) the proposed order;
(B) proposed findings with respect to the de-
gree of risk of illness or injury designed to be
eliminated or reduced by requiring the device
to have an approved application for premarket
approval and the benefit to the public from
use of the device;
(C) opportunity for the submission of com-
ments on the proposed order and the proposed
findings; and
(D) opportunity to request a change in the
classification of the device based on new infor-
mation relevant to the classification of the de-
vice.
(3) After the expiration of the period for com-
ment on a proposed order and proposed findings
published under paragraph (2), consideration of
comments submitted on such proposed order and
findings, and a meeting of a device classification
panel described in section 360c(b) of this title,
the Secretary shall (A) issue an administrative
order under paragraph (1) and publish in the
Federal Register findings on the matters re-
ferred to in paragraph (2)(B), or (B) publish a no-
tice terminating the proceeding for the issuance
of the administrative order together with the
reasons for such termination. If a notice of ter-
mination is published, the Secretary shall (un-
less such notice is issued because the device is a
banned device under section 360f of this title)
initiate a proceeding under section 360c(e) of
this title to reclassify the device subject to the
proceeding terminated by such notice.
(c) Application for premarket approval
(1) Any person may file with the Secretary an
application for premarket approval for a class
Cross-references
Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Reasonable assurance of safe and effective performance; periodic evaluation**
(1) The special controls required by [section 360c(a)(1)(B) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section360c/a/1/B&num=0&edition=prelim) shall include performance standards for a class II device if the Secretary determines that a performance standard is necessary to provide reasonable assurance of the safety and effectiveness of the device. A class III device may also be considered a class II device for purposes of establishing a standard for the device under subsection (b) if the device has been reclassified as a class II device under an administrative order under [section 360c(e) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section360c/e&num=0&edition=prelim) (or a regulation promulgated under such section prior to July 9, 2012) but such order (or regulation) provides that the reclassification is not to take effect until the effective date of such a standard for the device.
(2) A performance standard established under subsection (b) for a device—
(A) shall include provisions to provide reasonable assurance of its safe and effective performance;
(B) shall, where necessary to provide reasonable assurance of its safe and effective performance, include—
(i) provisions respecting the construction, components, ingredients, and properties of the device and its compatibility with power systems and connections to such systems,
(ii) provisions for the testing (on a sample basis or, if necessary, on an individual basis) of the device or, if it is determined that no other more practicable means are available to the Secretary to assure the conformity of the device to the standard, provisions for
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 360d
Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.
Federal law — U.S. Code and appendices · legal_authorities
For purposes of this subpart:
(1) The term “premarket application” means—
(A) an application for approval of a device submitted under [section 360e(c) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section360e/c&num=0&edition=prelim) or [section 262 of title 42](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section262&num=0&edition=prelim); or
(B) a product development protocol described in [section 360e(f) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section360e/f&num=0&edition=prelim).
Such term does not include a supplement, a premarket report, or a premarket notification submission.
(2) The term “premarket report” means a report submitted under [section 360e(c)(2) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section360e/c/2&num=0&edition=prelim).
(3) The term “premarket notification submission” means a report submitted under [section 360(k) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section360/k&num=0&edition=prelim).
(4)
(A) The term “supplement”, with respect to a panel-track supplement, a 180-day supplement, a real-time supplement, or an efficacy supplement, means a request to the Secretary to approve a change in a device for which—
(i) an application or report has been approved under [section 360e(d) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section360e/d&num=0&edition=prelim), or an application has been approved under [section 262 of title 42](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section262&num=0&edition=prelim); or
(ii) a notice of completion has become effective under [section 360e(f) o
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 379i
Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 379i. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 545
TITLE 21—FOOD AND DRUGS
§ 379i
SUBPART 3—FEES RELATING TO DEVICES
§ 379i. Definitions
For purposes of this subpart:
(1)
The
term
‘‘premarket
application’’
means—
(A) an application for approval of a device
submitted under section 360e(c) of this title
or section 262 of title 42; or
(B) a product development protocol de-
scribed in section 360e(f) of this title.
Such term does not include a supplement, a
premarket report, or a premarket notification
submission.
(2) The term ‘‘premarket report’’ means a re-
port submitted under section 360e(c)(2) of this
title.
(3) The term ‘‘premarket notification sub-
mission’’ means a report submitted under sec-
tion 360(k) of this title.
(4)(A) The term ‘‘supplement’’, with respect
to a panel-track supplement, a 180-day supple-
ment, a real-time supplement, or an efficacy
supplement, means a request to the Secretary
to approve a change in a device for which—
(i) an application or report has been ap-
proved under section 360e(d) of this title, or
an application has been approved under sec-
tion 262 of title 42; or
(ii) a notice of completion has become ef-
fective under section 360e(f) of this title.
(B) The term ‘‘panel-track supplement’’
means a supplement to an approved premarket
application or premarket report under section
360e of this title that requests a significant
change in design or performance of the device,
or a new indication for use of the device, and
for which substantial clinical data are nec-
essary to provide a reasonable assurance of
safety and effectiveness.
(C) The term ‘‘180-day supplement’’ means a
supplement to an approved premarket applica-
tion or premarket report under section 360e of
this title that is not a panel-track supplement
and requests a significant change
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 379i
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 379i. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
**(a) Types of fees**
(1) **In general** — Beginning in fiscal year 2023, the Secretary shall assess and collect fees in accordance with this section.
(2) **Premarket application, premarket report, supplement, and submission fee, and annual fee for periodic reporting concerning a class III device**
(A) *In general* — Except as provided in subparagraph (B) and subsections (d) and (e), each person who submits any of the following, on or after October 1, 2022, shall be subject to a fee established under subsection (c) for the fiscal year involved in accordance with the following:
(i) A premarket application.
(ii) For a premarket report, a fee equal to the fee that applies under clause (i).
(iii) For a panel track supplement, a fee equal to 80 percent of the fee that applies under clause (i).
(iv) For a 180-day supplement, a fee equal to 15 percent of the fee that applies under clause (i).
(v) For a real-time supplement, a fee equal to 7 percent of the fee that applies under clause (i).
(vi) For a 30-day notice, a fee equal to 1.6 percent of the fee that applies under clause (i).
(vii) For an efficacy supplement, a fee equal to the fee that applies under clause (i).
(viii) For a premarket notification submission, a fee equal to 4.5 percent of the fee that applies under clause (i).
(ix) For a request for classification information, a fee equal to 1.35 percent of the fee that applies under clause (i).
(x) For periodic reporting concerning a class III device, an annual fee equal to 3.5 percent of the fee that applies under clause (i).
(xi) For a de novo classification request, a fee equal to 30 percent of the fee that applies under clause (i).
(B) *Exceptions*
(i) *Humanitarian device exemption* — An applicati
Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 379j
Stored review status: release_metadata_unconfirmed. The source passage cites 21 U.S.C. § 379j. This identifies an authority to review, not proof of applicability.
Federal law — U.S. Code and appendices · legal_authorities
Page 549
TITLE 21—FOOD AND DRUGS
§ 379j
of fees paid for each such type of application or noti-
fication, from businesses with gross receipts or sales
from $0 to $100,000,000, with such businesses cat-
egorized in $10,000,000 intervals; and
‘‘(2) a certification by the Secretary that the
amounts appropriated for salaries and expenses of the
Food and Drug Administration for such fiscal year
and obligated by the Secretary for the performance of
any function relating to devices that is not for the
process for the review of device applications, as de-
fined in paragraph (5) [now (8)] of section 737 of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379i),
are not less than such amounts for fiscal year 2002
multiplied by the adjustment factor, as defined in
paragraph (7) [now (10)] of such section 737.’’
STUDY
Pub. L. 107–250, title I, § 104(b), Oct. 26, 2002, 116 Stat.
1601, directed the Secretary of Health and Human Serv-
ices to conduct a study for the purpose of making cer-
tain determinations regarding the medical device user-
fee program established under the amendment made by
section 102 of Pub. L. 107–250 and to submit a report to
Congress by Jan. 10, 2007.
CONSULTATION
Pub. L. 107–250, title I, § 105, Oct. 26, 2002, 116 Stat.
1601, provided that:
‘‘(a) IN GENERAL.—In developing recommendations to
the Congress for the goals and plans for meeting the
goals for the process for the review of medical device
applications for fiscal years after fiscal year 2007, and
for the reauthorization of sections 737 and 738 of the
Federal Food, Drug, and Cosmetic Act [21 U.S.C. 379i,
379j], the Secretary of Health and Human Services (re-
ferred to in this section as the ‘Secretary’) shall con-
sult with the Committee on Energy and Commerce of
the House
Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 379j
Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 379j. This identifies an authority to review, not proof of applicability.